ADAM17 and COVID-19: Our multivariable MR analysis suggested a direct causal role of ADAM17 (extracellular domain) on critical COVID-19 (OR = 1.09; 95% CI: 1.01–1.17) after accounting for body mass index (BMI), which is a risk factor suggested to have a causal effect on severe COVID-19 [14,15].